Thrombocytosis

Thrombocytosis is a topic covered in the Washington Manual of Medical Therapeutics.

To view the entire topic, please or .

The Washington Manual is an award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:

-- The first section of this topic is shown below --

General Principles

Definition

Thrombocytosis is defined as a platelet count of >450 × 109/L by the World Health Organization (WHO).

Etiology

Thrombocytosis has reactive and clonal etiologies that may coexist.

  • Reactive thrombocytosis may occur during recovery from thrombocytopenia; after splenectomy; or in response to iron deficiency, acute infectious or chronic inflammatory states, trauma, and malignancies.
    • Low risks of thrombosis or bleeding.
    • Platelets normalize after improvement of the underlying disorder.
    • If accompanied by thrombotic complications, evaluate for an underlying myeloproliferative disorder.

-- To view the remaining sections of this topic, please or --

General Principles

Definition

Thrombocytosis is defined as a platelet count of >450 × 109/L by the World Health Organization (WHO).

Etiology

Thrombocytosis has reactive and clonal etiologies that may coexist.

  • Reactive thrombocytosis may occur during recovery from thrombocytopenia; after splenectomy; or in response to iron deficiency, acute infectious or chronic inflammatory states, trauma, and malignancies.
    • Low risks of thrombosis or bleeding.
    • Platelets normalize after improvement of the underlying disorder.
    • If accompanied by thrombotic complications, evaluate for an underlying myeloproliferative disorder.

There's more to see -- the rest of this topic is available only to subscribers.